Recent News

• 04.09.2025 - 24th Annual Needham Virtual Healthcare Conference
• 04.09.2025 - 24th Annual Needham Virtual Healthcare Conference
• 04.08.2025 - Harmony Biosciences Presents Promising Open-Label Extension Data of ZYN002 in Fragile X Syndrome
• 04.08.2025 - Harmony Biosciences Presents Promising Open-Label Extension Data of ZYN002 in Fragile X Syndrome
• 04.07.2025 - Ron Philip
• 04.07.2025 - Ron Philip
• 04.03.2025 - Harmony Biosciences Appoints Biotech Leader Ron Philip to Its Board of Directors
• 04.03.2025 - Harmony Biosciences Appoints Biotech Leader Ron Philip to Its Board of Directors
• 03.26.2025 - Harmony Biosciences to Participate in 24th Annual Needham Virtual Healthcare Conference
• 03.26.2025 - Harmony Biosciences to Participate in 24th Annual Needham Virtual Healthcare Conference

Recent Filings

• 04.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.04.2025 - ARS Annual Report to Security Holders
• 04.04.2025 - DEF 14A Other definitive proxy statements
• 04.04.2025 - 3 Initial statement of beneficial ownership of securities
• 04.04.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.03.2025 - EX-99.1 EX-99.1
• 04.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.03.2025 - 8-K Current report
• 04.01.2025 - 144 Report of proposed sale of securities
• 04.01.2025 - 4 Statement of changes in beneficial ownership of securities